Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice

被引：11

作者：

Romano, L

Peduzzi, C

Venturi, G

Di Pietro, M

Carli, T

Corsi, P

Gonnelli, A

Valensin, PE

Zazzi, M

机构：

[1] Univ Siena, Dipartimento Biol Mol, Sez Microbiol, I-53100 Siena, Italy

[2] Osped S M Annunziata, UO Malattie Infettive, Florence, Italy

[3] Azienda Ospedaliere Grosseto, U O Malattie Infettive, Grosseto, Italy

[4] Azienda Ospedaliera Careggi, U O Malattie Infettive, Florence, Italy

[5] Azienda Ospedaliera Senese, U O Malattie Infettive, Siena, Italy

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2002年 / 30卷 / 05期

关键词：

D O I：

10.1097/00126334-200208150-00010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：533 / 535

页数：3

共 9 条

[1]

BRUN S, 2001, 8 EUR C CLIN ASP TRE

[2]

Feinberg J, 2000, AIDS, V14, pS46

[3]

Johnson M, 2000, AIDS, V14, pS7

[4] Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients [J].

Kempf, DJ ;

Isaacson, JD ;

King, MS ;

Brun, SC ;

Xu, Y ;

Real, K ;

Bernstein, BM ;

Japour, AJ ;

Sun, E ;

Rode, RA .

JOURNAL OF VIROLOGY, 2001, 75 (16) :7462-7469

[5]

PEDUZZI C, IN PRESS J CLIN VIRO

[6]

REITMAYER R, 2001, 8 C RETR OPP INF CHI

[7]

Rockstroh J, 2000, AIDS, V14, pS29

[8] ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease [J].

Sham, HL ;

Kempf, DJ ;

Molla, A ;

Marsh, KC ;

Kumar, GN ;

Chen, CM ;

Kati, W ;

Stewart, K ;

Lal, R ;

Hsu, A ;

Betebenner, D ;

Korneyeva, M ;

Vasavanonda, S ;

McDonald, E ;

Saldivar, A ;

Wideburg, N ;

Chen, XQ ;

Niu, P ;

Park, C ;

Jayanti, V ;

Grabowski, B ;

Granneman, GR ;

Sun, E ;

Japour, AJ ;

Leonard, JM ;

Plattner, JJ ;

Norbeck, DW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3218-3224

[9]

THOMPSON M, 2001, 8 EUR C CLIN ASP TRE

← 1 →